CABA · Cabaletta Bio, Inc. · Fails to Deliver
$1.33
-0.12 (-8.28%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— cleared Nov 5, 2026
The latest filing states the doubt was alleviated.
“As disclosed in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, we had previously identified conditions that raised substantial doubt about our ability to continue as a going concern. During the quarter ended September 30, 2026, we raised additional funds through the exercise of common stock warrants for proceeds of $115.0 million and sold 1.9 million shares pursuant to the 2025 ATM Program for net proceeds of $6.0 million. As a result of these cash raises, the conditions that previously raised substantial doubt are no longer present.”View the 10-Q filed Nov 5, 2026
Market Cap
$286.91M
Shares
215.72M
Volume · Nov 12
3.73M
Avg daily vol (3M)
5.32M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-08 | 3,695 | $1.97 | $7,279 |
| 2026-10-07 | 809 | $2.02 | $1,634 |
| 2026-10-05 | 962 | $2.00 | $1,924 |
| 2026-09-22 | 4,843 | $2.46 | $11,914 |
| 2026-09-03 | 8 | $3.57 | $29 |
| 2026-08-28 | 63,795 | $3.38 | $215,627 |
| 2026-08-25 | 1 | $3.10 | $3 |
| 2026-08-19 | 1,973 | $2.91 | $5,741 |
| 2026-08-13 | 3 | $2.85 | $9 |
Showing 1–9 of 9 settlements
Key facts
CIK
1759138
CUSIP
12674W109
13F (30d)
80 filings
71 filers
Visit website
Investor relations